GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TiumBio Co Ltd (XKRX:321550) » Definitions » Scaled Net Operating Assets

TiumBio Co (XKRX:321550) Scaled Net Operating Assets : 0.32 (As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is TiumBio Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TiumBio Co's operating assets for the quarter that ended in Dec. 2024 was ₩56,674 Mil. TiumBio Co's operating liabilities for the quarter that ended in Dec. 2024 was ₩26,359 Mil. TiumBio Co's Total Assets for the quarter that ended in Sep. 2024 was ₩94,348 Mil. Therefore, TiumBio Co's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.32.


TiumBio Co Scaled Net Operating Assets Historical Data

The historical data trend for TiumBio Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TiumBio Co Scaled Net Operating Assets Chart

TiumBio Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Scaled Net Operating Assets
Get a 7-Day Free Trial 0.16 0.81 0.43 0.61 0.25

TiumBio Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.51 0.50 0.50 0.32

Competitive Comparison of TiumBio Co's Scaled Net Operating Assets

For the Biotechnology subindustry, TiumBio Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TiumBio Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TiumBio Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where TiumBio Co's Scaled Net Operating Assets falls into.


;
;

TiumBio Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

TiumBio Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2024 )
=(Operating Assets (A: Dec. 2024 )-Operating Liabilities (A: Dec. 2024 ))/Total Assets (A: Dec. 2023 )
=(56674.259-26359.004)/119546.025
=0.25

where

Operating Assets(A: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=107298.482 - 50624.223
=56674.259

Operating Liabilities(A: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=56538.781 - 16680.158 - 13499.619
=26359.004

TiumBio Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(56674.259-26359.004)/94347.703
=0.32

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=107298.482 - 50624.223
=56674.259

Operating Liabilities(Q: Dec. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=56538.781 - 16680.158 - 13499.619
=26359.004

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TiumBio Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of TiumBio Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


TiumBio Co Business Description

Traded in Other Exchanges
N/A
Address
49, Daewangpangyo-ro 644beon-gil, Bundang-gu, 4th floor, Gyeonggi, Seongnam, KOR, 13493
TiumBio Co Ltd is a Biopharmaceutical company. It is engaged in research and development of rare and intractable diseases. The company's products are in pipeline. It offers products such as Idiopathic pulmonary fibrosis therapies, immune chemotherapy, endometriosis therapies, hemophilia.

TiumBio Co Headlines

No Headlines